Neuropathology of scizophrenia - From a new perspective

Brain and Nerve

Volumn 59, Issue 6, 2007, Pages 605-616

  Iritani, Shuji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Neuroimaging; Neuropathology; Schizophrenia; Susceptibility gene; Synapse

Indexed keywords

ALZHEIMER DISEASE; BRAIN DYSFUNCTION; CLINICAL OBSERVATION; COMPUTER ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; FRONTAL LOBE; FUNCTIONAL DISEASE; GENETIC ANALYSIS; HISTOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MENTAL PATIENT; MICROSCOPY; NERVE CELL DIFFERENTIATION; NERVE CELL NETWORK; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; TEMPORAL LOBE;

BRAIN; HUMANS; NEUROFIBRILS; NEUROTRANSMITTER AGENTS; SCHIZOPHRENIA; SYNAPSES;

EID: 34347325266     PISSN: 00068969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Aganova EA, Uranova NA: Morphometric analysis of synaptic contacts in the anterior limbic cortex in the endogenous psychoses. Neurosci Behav Physiol 22: 59-65, 1992
2. Agartz I, Sedvall GC, Terenius L, Kulle B, Jonsson EG, et al: BDNF gene variants and brain morphology in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 141: 513-523, 2006
3. Akbarian S, Bunney WE Jr, Potkin SG, Wigal SB, Jones EG, et al: Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 50: 169-177, 1993a
4. Akbarian S, Vinuela A, Kim JJ, Potkin SG, Jones EG, et al: Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 50: 178-187, 1993b
5. Altshuler LL, Casanova MF, Goldberg TE, Kleinman JE: The hippocampus and parahippocampus in schizophrenia, suicide, and control brains. Arch Gen Psychiatry 47: 1029-1034, 1990 Erratum in: Arch Gen Psychiatry 48: 422, 1991
6. Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR: Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 48: 625-632, 1991a
7. Arnold SE, Lee VM, Gur RE, Trojanowski JQ: Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci U S A 88: 10850-10854, 1991b
8. Arnold SE, Franz BR, Gur RC, Gur RE, Trojanowski JQ, et al: Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry 152: 738-748, 1995
9. Arnold SE, Trojanowski JQ: Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol (Berl) 92: 217-231, 1996
10. Ashe PC, Berry MD, Boulton AA: Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. Prog Neuropsychopharmacol Biol Psychiatry 25: 691-707, 2001
11. Benes FM, Davidson J, Bird ED: Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry 43: 31-35, 1986
12. Benes FM, Bird ED: An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch Gen Psychiatry 44: 608-616, 1987a
13. Benes FM, Majocha R, Bird ED, Marotta CA: Increased vertical axon numbers in cingulate cortex of schizophrenics. Arch Gen Psychiatry 44: 1017-1021, 1987b
14. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL: Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48: 996-1001, 1991
15. Benes FM: Neurobiological investigations in cingulate cortex of schizophrenic brain. Schizophr Bull 19: 537-549, 1993
16. Benes FM, Todtenkopf MS, Taylor JB: Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain. Synapse 25: 80-92, 1997
17. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS: A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 44: 88-97, 1998
18. Benes FM, Todtenkopf MS, Logiotatos P, Williams M: Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain. J Chem Neuroanat 20: 259-269, 2000
19. Bogerts B, Falkai P, Haupts M, Greve B, Heinzmann U, et al: Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection. Schizophr Res 3: 295-301, 1990
20. Bogerts B, Meertz E, Schonfeldt-Bausch R: Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch Gen Psychiatry 42: 784-791, 1985
21. Browning MD, Dudek EM, Rapier JL, Leonard S, Freedman R: Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry 34: 529-535, 1993
22. Burnet PW, Eastwood SL, Harrison PJ: 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacol 15: 442-455, 1996
23. Casanova MF, Carosella N, Kleinman JE: Neuropathological findings in a suspected case of childhood schizophrenia. J Neuropsychiatry Clin Neurosci 2: 313-319, 1990
24. Chana G, Landau S, Beasley C, Everall IP, Cotter D: Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiatry 53: 1086-1098, 2003
25. Chowdari KV, Mimics K, Semwal P, Wood J, Nimgaonkar VL, et al: Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 11: 1373-1380, 2002 Erratum in: Hum Mol Genet 12: 1781, 2003
26. Colter N, Battal S, Crow TJ, Johnstone EC, Bruton C, et al: White matter reduction in the parahippocampal gyrus of patients with schizophrenia. Arch Gen Psychiatry 44: 1023, 1987
27. Conrad AJ, Abebe T, Austin R, Forsythe S, Scheibel AB: Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch Gen Psychiatry 48: 413-417, 1991
28. Corfas G, Roy K, Buxbaum JD: Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 7: 575-580, 2004
29. Davidson M, Reichenberg A, Rabinowitz J, Weiser M, Mark M, et al: Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry 156: 1328-1335, 1999
30. Dickey CC, Salisbury DF, Nagy AI, Hirayasu Y, Shenton ME, et al: Follow-up MRI study of prefrontal volumes in first-episode psychotic patients. Schizophr Res 71: 349-351, 2004 No abstract available.
31. Eastwood SL, Harrison PJ: Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 69: 339-343, 1995
32. Eastwood SL, Harrison PJ: Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol Psychiatry 5: 425-432, 2000
33. Eastwood SL, Harrison PJ: Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr Res 73: 159-172, 2005
34. Gabriel SM, Haroutunian V, Powchik P, Honer WG, Davis KL, et al: Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. Arch Gen Psychiatry. 54: 559-566, 1997 Erratum in: Arch Gen Psychiatry 54: 912, 1997
35. Garey LJ, Ong WY, Patel TS, Kanani M, Hirsch SR, et al: Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 65: 446-453, 1998
36. Glantz LA, Lewis DA: Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch Gen Psychiatry 54: 943-952, 1997
37. Glantz LA, Lewis DA: Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 57: 65-73, 2000
38. Gourion D, Goldberger C, Bourdel MC, Jean Bayle F, Krebs MO, et al: Minor physical anomalies in patients with schizophrenia and their parents: prevalence and pattern of craniofacial abnormalities. Psychiatry Res 125: 21-28, 2004
39. Grant SG: Synapse signalling complexes and networks: machines underlying cognition. Bioessays 25: 1229-1235, 2003
40. Halim ND, Weickert CS, McClintock BW, Hyde TM, Lipska BK, et al: Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development. Mol Psychiatry 8: 797-810, 2003
41. Harrison PJ, Burnet PW: The 5-HT2A (serotonin2A) receptor gene in the aetiology, pathophysiology and pharmacotherapy of schizophrenia. J Psychopharmacol 11: 18-20, 1997
42. Harrison PJ, Eastwood SL: Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 352: 1669-1673, 1998 Erratum in: Lancet 353: 154, 1999
43. Harrison PJ: The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122: 593-624, 1999
44. Harrison PJ, Weinberger DR: Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10: 40-68, 2005 image 5. Review. Erratum in: Mol Psychiatry 10: 420, 2005 Mol Psychiatry 10: 804, 2005
45. Hashimoto R, Straub RE, Weickert CS, Hyde TM, Weinberger DR, et al: Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry 9: 299-307, 2004
46. Heckers S, Heinsen H, Heinsen YC, Beckmann H: Limbic structures and lateral ventricle in schizophrenia. A quantitative postmortem study. Arch Gen Psychiatry 47: 1016-1022, 1990
47. Heckers S, Heinsen H, Heinsen Y, Beckmann H: Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study. Biol Psychiatry 29: 556-566, 1991
48. Honer WG, Falkai P, Young C, Wang T, Trimble WS, et al: Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neuroscience 78: 99-110, 1997
49. Honer WG, Falkai P, Chen C, Arango V, Dwork AJ, et al: Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience 91: 1247-1255, 1999
50. Huttunen MO, Machon RA, Mednick SA: Prenatal factors in the pathogenesis of schizophrenia. Br J Psychiatry Suppl 23: 15-19, 1994
51. Japanese source
52. Javitt DC, Zukin SR: Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308, 1991
53. Jönsson EG, Edman-Ahlbom B, Sillen A, Gunnar A, Terenius L, et al: Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog Neuropsychopharmacol Biol Psychiatry 30: 924-933, 2006 (Epub 2006 Apr 3)
54. Kamiya A, Kubo K, Tomoda T, et al: A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 7: 1167-1178, 2005
55. Karson CN, Mrak RE, Schluterman KO, Sturner WQ, Griffin WS, et al: Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. Mol Psychiatry 4: 39-45, 1999
56. Keilhoff G, Bernstein HG, Becker A, Grecksch G, Wolf G: Increased neurogenesis in a rat ketamine model of schizophrenia. Biol Psychiatry 56: 317-322, 2004
57. Kerwin R, Patel S, Meldrum B: Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience 39: 25-32, 1990
58. Kolomeets NS, Orlovskaya DD, Rachmanova VI, Uranova NA: Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: a postmortem morphometric study. Synapse 57: 47-55, 2005
59. Konopaske GT, Sweet RA, Wu Q, Sampson A, Lewis DA: Regional specificity of chandelier neuron axon terminal alterations in schizophrenia. Neuroscience 138: 189-196, 2006 (Epub 2005 Dec 7)
60. Kunugi H, Vallada HP, Sham PC, Hoda F, Collier DA, et al: Catechol-O-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families. Psychiatr Genet 7: 97-101, 1997
61. Kunugi H, Nanko S, Murray RM: Obstetric complications and schizophrenia: prenatal underdevelopment and subsequent neurodevelopmental impairment. Br J Psychiatry Suppl 40: s25-s29, 2001
62. Lemke G: Neuregulin-1 and myelination. Sci STKE 2006 (325): pe11.
63. Lewis DA, Levitt P: Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25: 409-432, 2002 [Epub 2002 Mar 22]
64. McInnes LA, Lauriat TL: RNA metabolism and dysmyelination in schizophrenia. Neurosci Biobehav Rev 30: 551-561, 2006 (Epub 2006 Jan 30)
65. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P: Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 6: 293-301, 2001
66. Niemi LT, Suvisaari JM, Tuulio-Henriksson A, Lonnqvist JK: Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophr Res 60: 239-258, 2003
67. Numakawa T, Yagasaki Y, Ishimoto T, Okada T, Hashimoto R, et al: Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet 13: 2699-2708, 2004 (Epub 2004 Sep 2)
68. Ohnishi T, Hashimoto R, Mori T, Nemoto K, Kunugi H, et al: The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 129: 399-410, 2006 (Epub 2005 Dec 5)
69. Ohnuma T, Kato H, Arai H, Faull RL, Emson PC, et al: Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia. Neuroreport 11: 3133-3137, 2000
70. Okabe S, Collin C, Auerbach JM, Meiri N, McKay RD, et al: Hippocampal synaptic plasticity in mice overexpressing an embryonic subunit of the NMDA receptor. J Neurosci 18: 4177-4188, 1998
71. Olin SC, Mednick SA, Cannon T, Jacobsen B, Schulsinger H, et al: School teacher ratings predictive of psychiatric outcome 25 years later. Br J Psychiatry (Suppl) 172: 7-13, 1998
72. Owens DF, Kriegstein AR: Developmental neurotransmitters? Neuron 36: 989-991, 2002
73. Ozeki Y, Tomoda T, Kleiderlein J et al: Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci U S A 100: 289-294, 2003
74. Perrone-Bizzozero NI, Sower AC, Bird ED, Benowitz LI, Neve RL, et al: Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci U S A 93: 14182-14187, 1996
75. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Weinberger DR, et al: The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24: 10099-10102, 2004
76. Pierri JN, Chaudry AS, Woo TU, Lewis DA: Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry 156: 1709-1719, 1999
77. Porter RH, Eastwood SL, Harrison PJ: Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia. Brain Res 751: 217-231, 1997
78. Price G, Cercignani M, Bagary MS, Barnes TR, Ron MA, et al: A volumetric MRI and magnetization transfer imaging follow-up study of patients with first-episode schizophrenia. Schizophr Res 87: 100-108, 2006 (Epub 2006 Jul 14)
79. Roberts RC, Roche JK, Conley RR: Synaptic differences in the patch matrix compartments of subjects with schizophrenia: a postmortem ultrastructural study of the striatum. Neurobiol Dis 20: 324-335, 2005
80. Sawada K, Barr AM, Nakamura M, Arima K, Honer WG, et al: Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry 62: 263-272, 2005
81. Selemon LD, Rajkowska G, Goldman-Rakic PS: Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 52: 805-818, (discussion 819-820) 1995
82. Shenton ME, Dickey CC, Frumin M, McCarley RW: A review of MRI findings in schizophrenia. Schizophr Res 49: 1-52, 2001
83. Talbot K, Eidem WL, Tinsley CL, Benson MA, Arnold SE, et al: Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 113: 1353-1363, 2004
84. Tatetsu S: A contribution of the morphological back ground of Schizophrenia, With special reference to the findings in the Telencephalon. Acta Neuropathologica 3: 558-571, 1960
85. Thompson PM, Sower AC, Perrone-Bizzozero NI: Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol Psychiatry 43: 239-243, 1998
86. Toyooka K, Iritani S, Makifuchi T, Shirakawa O, Nawa H, et al: Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J Neurochem 83: 797-806, 2002
87. Tsuang DW, Faraone SV, Tsuang MT: Genetic counseling for psychiatric disorders. Curr Psychiatry Rep 3: 138-143, 2001
88. Young CE, Arima K, Xie J, Hu L, Honer WG, et al: SNAP-25 deficit and hippocampal connectivity in schizophrenia. Cereb Cortex 8: 261-268, 1998
89. Volk DW, Pierri JN, Fritschy JM, Auh S, Lewis DA, et al: Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex 12: 1063-1070, 2002
90. Wassink TH, Nopoulos P, Pietila J, Crowe RR, Andreasen NC: NOTCH4 and the frontal lobe in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 118: 1-7, 2003
91. Woo TU, Whitehead RE, Melchitzky DS, Lewis DA: A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci U S A 95: 5341-5346, 1998
92. Zakzanis KK, Hansen KT: Dopamine D2 densities and the schizophrenic brain. Schizophr Res 32: 201-206, 1998